NCT04392739View on ClinicalTrials.gov

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

PHASE4CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

July 19, 2019

Primary Completion Date

December 5, 2019

Study Completion Date

December 5, 2019

Conditions

Smallpox

Interventions

DRUG

Tpoxx

oral antiviral

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors

Collaborators (1)

PPD Development, LP

All Listed Sponsors

collaborator

Biomedical Advanced Research and Development Authority

FED

collaborator

PPD Development, LP

INDUSTRY

lead

SIGA Technologies

INDUSTRY